Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Credit agrmnt [a]
Inv. presentation
Quarterly results
Appointed director
CC transcript
|
|
Unilife Corp (UNIS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/16/2016 |
8-K
| Credit agreement amendment |
| 02/01/2016 |
8-K
| Credit agreement amendment |
| 01/07/2016 |
8-K
| Credit agreement amendment |
| 10/16/2015 |
8-K
| Credit agreement amendment|
Docs:
|
"Third Amendment to Credit Agreement, by and among Unilife Medical Solutions, Inc. and ROS Acquisition Offshore LP",
"Second Amendment to Royalty Agreement, by and among Unilife Medical Solutions, Inc. and Royal Opportunities S.À R.L",
"Amended and Restated Promissory Note, for up to $70,000,000 by Unilife Medical Solutions, Inc. in favor of ROS Acquisition Offshore LP",
"Unilife Announces Additional Financing of up to $10 Million from OrbiMed and Implements an Additional Cost Reduction Initiative YORK, Pa., October 16, 2015/PRNewswire/ — Unilife Corporation today announced the signing of an agreement with an affiliate of OrbiMed for the provision of up to an additional $10 million in debt financing. The material terms are described in a Form 8-K filed by the Company with the SEC today. In addition, Unilife this week implemented an additional cost reduction initiative, including a significant decrease in executive compensation, to further reduce the Company's operating expenses in order to maximize shareholder value in connection with the continuing review of strategic alternatives, for which Morgan Stanley & Co. LLC is engaged as its financial advisor, an..." |
|
|
|